Long-lived immune cells show promise against cancer in world-first trial

Conventional CAR T cells (purple and yellow spheres; artificially coloured) attack a cancer cell.Credit: Steve ...

Low-dose oral nicotinamide mononucleotide for immune thrombocytopenia: a phase 1/2 trial

Gatto, M., Zen, M., Cruciani, C., Iaccarino, L. & Doria, A. Navigating the landscape of ...

Clinical trial results support use of weekly extended-release buprenorphine for treatment of opioid use disorder during pregnancy

Monday, March 16, 2026 NIH-supported study shows this treatment resulted in higher rates of illicit opioid abstinence than current standard of care. ...

Ipilimumab and nivolumab followed by chemoradiotherapy as bladder-sparing treatment in muscle-invasive bladder cancer: a phase 2 trial

Competing interests M.S.v.d.H. has received institutional funding from Bristol Myers Squibb to finance the INDIBLADE ...

Type 2 Diabetes

An experimental GLP-1 pill may help people with type 2 diabetes reduce their blood sugar ...

Laser interstitial thermal therapy and adjuvant pembrolizumab in recurrent high-grade astrocytoma: a Phase 1/randomized Phase 2b trial

Study design and treatments Approval Human subject work was performed in accordance with an approved ...

Targeted innate immune inhibition therapy compared with antibiotics for recurrent acute cystitis: a randomized, open-label phase 2 trial

Study design For this randomized, open-label, single-centre, phase 2 trial, patients were enrolled at the ...

NIH halts arm of clinical trial evaluating a potential stroke treatment

Tuesday, February 10, 2026 Study found low-dose rivaroxaban to be unsafe and ineffective compared to ...

Live-attenuated chikungunya vaccine in children: a randomized phase 2 trial

Bartholomeeusen, K. et al. Chikungunya fever. Nat. Rev. Dis. Primers 9, 17 (2023). Article  PubMed  ...

Breakthrough sepsis drug shows promise in human trial

Researchers at Griffith University report encouraging progress toward treating sepsis after a Phase II clinical ...